About this trial
The purpose of this study is to determine how a ketone ester supplement affects brain function, brain blood flow, and brain metabolism in healthy middle-aged and older adults. Ketones are naturally produced by the body during periods of fasting or carbohydrate restriction and serve as an alternative fuel source for the brain. Researchers are interested in whether increasing blood ketone levels through supplementation can alter brain activity and blood flow in ways that may support healthy brain function.
Participants will consume a ketone ester supplement and a placebo in separate study visits. Brain imaging, blood measurements, and cognitive testing will be used to evaluate the effects of each intervention. Findings from this study will help researchers better understand how ketones influence the healthy aging brain and may provide preliminary data for future studies in populations at risk for cognitive decline.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥45 years and ≤65 years
Able to comply with study requirements including presenting for each test session following an overnight fast and not following a ketogenic diet during the duration of the study.
BMI between 18.5 and 30 kg/m2
Disqualifiers
Non-English Speaking
Currently taking a ketone ester supplement, ketone salt supplement, or on a ketogenic diet
Pregnancy, a urine pregnancy test will be given to all women before scanning to confirm nonpregnant status
Currently breastfeeding
Trial design
Crossover
Treatments tested in this trial
Ketone Ester Drink
Dietary supplementThe ketone ester beverage contains 25 g of C8 Diester emulsified in a matrix of water, whey protein concentrate, modified gum acacia, natural and artificial flavors and cocoa powder. It contains 210 kcal, 0.5 g fat, 2 g carbohydrates, and 2 g protein. Dose consumed is 50 g, 2 times per day for 2 days. The placebo (PL) will be calorie and volume matched to the KE and be formulated with standard dietary ingredients.
Placebo
Dietary supplementThe placebo drink will be calorie and volume matched to the KE and be formulated with standard dietary ingredients.
Treatment groups
Trial outcomes
Primary outcomes
Cerebral Blood Flow
To detect a clinically meaningful difference in cerebral blood flow (CBF) between ketone ester and placebo conditions in healthy adults
Brain Glutamate Concentration
To detect a difference in brain glutamate concentration (mM) between ketone ester and placebo conditions in healthy adults, measured using proton magnetic resonance spectroscopy (1H-MRS).
Brain GABA Concentration
To detect a difference in brain gamma-aminobutyric acid (GABA) concentration (mM) between ketone ester and placebo conditions in healthy adults, measured using proton magnetic resonance spectroscopy (1H-MRS).
Brain Lactate Concentration
To detect a difference in brain lactate concentration (mM) between ketone ester and placebo conditions in healthy adults, measured using proton magnetic resonance spectroscopy (1H-MRS).
Secondary outcomes
Blood Ketone Concentration
Blood beta-hydroxybutyrate concentrations measured by fingerstick testing.
Blood Glucose Concentration
Blood glucose concentrations measured by fingerstick testing.
Cognitive Performance (RBANS Total Scale Score)
Total Scale Score on the RBANS, comparing ketone ester and placebo conditions in healthy adults.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Christopher Crabtree
Lead sponsor
Ohio State University
Sponsor institution